e-learning
resources
Vienna 2009
Monday, 14.09.2009
Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results
S. Ley, J. Ley-Zaporozhan, F. M. Müller, J. Pöschl (Heidelberg, Germany)
Source:
Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Session:
Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Session type:
E-Communication Session
Number:
1728
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ley, J. Ley-Zaporozhan, F. M. Müller, J. Pöschl (Heidelberg, Germany). Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results. Eur Respir J 2009; 34: Suppl. 53, 1728
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
Severe COVID-19 pneumonia: clinical, functional, and imaging outcomes at 4 months
Source: Virtual Congress 2021 – Chronic COVID - 19
Year: 2021
Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Scottish pulmonary sarcoidosis – an exploratory analysis of prevalence, presentation and clinical data in nearly 200 patients
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009
Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
COPD comorbidities – Do they add more cost? A 1-year follow-up study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Predictors for developing hypoxic respiratory failure in COPD – A 3-year follow-up
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Lymphangioleiomyomatosis – Clinical characteristics and longitudinal follow-up of 36 cases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Interstitial lung diseases in children – Clinical and pathological characteristics
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Late Breaking Abstract: Pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF) in early course of disease – A prospective evaluation with right heart catheterization (RHC) in the ARTEMIS-IPF study
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Pulmonary sequelae in patients with COVID-19: results after 3 months of follow-up
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Pulmonary tuberculosis presentation – Late diagnosis, advanced disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
The journey to severe obstructive lung disease – Retrospective study of FEV1 decline
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Clinical parameters for predicting 3-month FEV
1
response of obstructive lung diseases in elderly patients
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Six minute walk test (6MWT) in patients with diagnosis of lung cancer – Clinical value in physiological evaluation candidates for surgical treatment
Source: Annual Congress 2012 - Pre-operative evaluation in thoracic surgery
Year: 2012
Imaging and functional disorders in occupational bronchiolitis, follow-up 1,7 years
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept